19-54311632-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_021250.4(LILRA5):c.494G>T(p.Arg165Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000558 in 1,614,016 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_021250.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LILRA5 | NM_021250.4 | c.494G>T | p.Arg165Leu | missense_variant | 5/7 | ENST00000432233.8 | NP_067073.1 | |
LILRA5 | NM_181985.4 | c.458G>T | p.Arg153Leu | missense_variant | 4/6 | NP_871714.1 | ||
LILRA5 | NM_181879.3 | c.494G>T | p.Arg165Leu | missense_variant | 5/5 | NP_870994.1 | ||
LILRA5 | NM_181986.3 | c.458G>T | p.Arg153Leu | missense_variant | 4/4 | NP_871715.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LILRA5 | ENST00000432233.8 | c.494G>T | p.Arg165Leu | missense_variant | 5/7 | 1 | NM_021250.4 | ENSP00000404236 | P2 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152124Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000398 AC: 10AN: 251460Hom.: 1 AF XY: 0.0000368 AC XY: 5AN XY: 135902
GnomAD4 exome AF: 0.0000602 AC: 88AN: 1461892Hom.: 0 Cov.: 31 AF XY: 0.0000646 AC XY: 47AN XY: 727248
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152124Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74308
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 28, 2023 | The c.494G>T (p.R165L) alteration is located in exon 5 (coding exon 5) of the LILRA5 gene. This alteration results from a G to T substitution at nucleotide position 494, causing the arginine (R) at amino acid position 165 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at